Agenus provides corporate update and third quarter 2022 financial report

Lexington, mass., nov. 08, 2022 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with a broad pipeline targeting cancers and infectious disease, today provided a corporate update and reported financial results for the third quarter of 2022.
AGEN Ratings Summary
AGEN Quant Ranking